Perioperative Blood Transfusion and Solid Tumor Recurrence—A Review

References

• Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978; 299: 799–803
   PubMed Web of Science ®Google Scholar
• Woodruff MFA, van Rood JJ. Possible implications of the effect of blood transfusion on allograft survival. Lancet 1983; i: 1201–1202
   Google Scholar
• Anonymous Blood transfusion and allograft survival. Lancet 1984; i: 830–831
   Google Scholar
• Taylor RMR, Ting A, Briggs JD. Renal transplatation in the United Kingdom and Ireland—the centre effect. Lancet 1985; i: 798–803
   Google Scholar
• Proud G, Shenton BK, Smith BM. Blood transfusion and renal transplantation. Br J Surg 1979; 66: 678–682
   PubMed Web of Science ®Google Scholar
• Yasumura T, Kahan BD. Immunosupression of renal allograft rejection by perioperative administration of the combination of histocompatibililty antigen in the form of 3M KCI extract or blood transfusion and cyclosporine. Transplant Proc 1983; 15: 2942–2949
   Web of Science ®Google Scholar
• Wakely E, Shelby J, Cony RJ. The effect of peripheral blood components on allograft survival. Transplantation 1985; 40: 113–114
   PubMed Web of Science ®Google Scholar
• Ohwa T, Hosokawa M, Imamura M, et al. Anti-tumour immunity by normal allogeneic blood transfusion in rat. Clin Exp Immunol 1977; 27: 549–554
   PubMed Web of Science ®Google Scholar
• Francis DMA, Shenton BK, Proud G, Taylor RMR. Tumor growth and blood transfusion. J Exp Clin Cancer Res 1982; 1: 121–126
   Google Scholar
• Horimi T, Kagawa S, Ninomiya M, et al. Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice. Acta Med Okayama 1983; 37: 259–263
   PubMed Web of Science ®Google Scholar
• Judson RT, Robb L, D'Apice AJF. Blood transfusion and tumor growth: an experimental study. Aust NZ J Surg 1985; 55: 503–506
   PubMedGoogle Scholar
• Jakobisiak M, Wlodarski K, Lasek W, et al. Transfusions of syngeneic blood do not seem to induce suppressive effect on anti-tumor or transplantation immunity in mice. Arch Immunol Therapiae Exp 1985; 33: 543–547
   PubMed Web of Science ®Google Scholar
• Marquet RL, de Bruin RWF, Dallinga RJ, et al. Modulation of tumor growth by allogeneic blood transfusion. J Cancer Res Clin Oncol 1986; 111: 50–53
   PubMed Web of Science ®Google Scholar
• Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrence rate. Lancet 1982; 662, letter
   PubMed Web of Science ®Google Scholar
• Agarwal M, Blumberg N. Colon cancer patients transfused perioperatively have an increased incidence of recurrence. Transfusion 23:421, 1983 (abstr). Br Med J 1985; 290: 1037–1039
   PubMed Web of Science ®Google Scholar
• Foster RS, Jr, Costanza MC, Foster JC, et al. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985; 55: 1195–1201
   PubMed Web of Science ®Google Scholar
• Ota D, Alvarez L, Lichtiger B, et al. Perioperative blood transfusions in patients with colon carcinoma. Transfusion 1985; 25: 392–394
   PubMed Web of Science ®Google Scholar
• Weiden PL, Bean MA, Schultz P, Thompson D. Perioperative blood transfusion does not increase risk of colorectal cancer recurrence. Blood 1984; 64: 232a, Suppl 1, abstract
   Google Scholar
• Frankish PD, McNee RK, Alley PG, Woodfield DG. Relation between cancer of the colon and blood transfusion. Br Med J 1985; 290: 1827, Letter
   PubMed Web of Science ®Google Scholar
• Francis D, Judson R. Relation between recurrence of cancer of the colon and blood transfusion. Br Med J 1985; 291: 544, Letter
   PubMed Web of Science ®Google Scholar
• Blair SD, Janvrin SB. Relation between cancer of the colon and blood transfusion. Br Med J 1985; 290: 1516–1517, Letter
   PubMed Web of Science ®Google Scholar
• Nathanson SD, Tilley BC, Schultz L, Smith RF. Perioperative allogeneic blood transfusions—survival in patients with resected carcinomas of the colon and rectum. Arch Surg 1985; 120: 734–738
   PubMed Web of Science ®Google Scholar
• Tartter PI, Burrows L, Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset NO) non-oat cell lung cancer. J Thoracic Cardiovasc Surg 1984; 88: 659–462
   PubMed Web of Science ®Google Scholar
• Hyman NH, Foser RS, Jr, DeMeules JE, Costanza MC. Blood transfusions and survival after lung cancer resection. Am J Surg 1985; 149: 502–507
   PubMed Web of Science ®Google Scholar
• Nowak MM, Ponsky JL. Blood transfusion and disease-free survival in carcinoma of the breast. J Surg Oncol 1984; 27: 124–130
   PubMed Web of Science ®Google Scholar
• Tartter PI, Burrows L, Papatestas AE, et al. Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 1985; 97: 225–229
   PubMed Web of Science ®Google Scholar
• Foster RS, Jr, Foster JC, Costanza MC. Blood transfusions and survival after surgery for breast cancer. Arch Surg 1984; 119: 1138–1140
   PubMed Web of Science ®Google Scholar
• Cohen E, Lane W, Rosner D, et al. Do blood transfusions adversely affect survival and metastatic interval following mastectomy. Proceedings of the International Society of Blood Transfusion. SydneyAustralia 1986; 490
   Google Scholar
• Blumberg N, Agarwal M, Chuang C. A possible Association between survival time and transfusion in patients with cervical cancer. Blood 1985; 66: 274a, Suppl 1, abstr
   Google Scholar
• Moffat LEF, Sunderland GT. Relation between recurrence of cancer and blood transfusion. Br Med J 1985; 291: 971
   PubMed Web of Science ®Google Scholar
• Manyonda IT, Shaw DE, Foulkes A, Osborn DE. Renal cell carcinoma: blood transfusion and survival. Br Med J 1986; 293: 537–538
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Seip CA, White DE, Wesley R. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol 1985; 3: 698–709
   PubMed Web of Science ®Google Scholar
• Dalrymple JC, Monaghan JM. Recurrent carcinoma of the vulva: relationship with operative blood transfusion. J Obstet Gynaecol (Great Britain) 1986; 7: 65–67
   PubMed Web of Science ®Google Scholar
• Kaneda M, Horimi T, Ninomiya M, et al. The effect of perioperative blood transfusion on patient's survival rate after gastric cancer surgery. Proceedings of the International Society of Blood Transfusion. SydneyAustralia 1986; 490
   Google Scholar
• Blumberg N, Heal JM, Murphy P, et al. Association between transfusion of whole blood and recurrence of cancer. Br Med J 1986; 293: 530–533
   PubMed Web of Science ®Google Scholar
• American Cancer Society, Cancer Statistics, 1985. CA—A Cancer Journal for Clinicians 1985; 35: 19–50
   PubMed Web of Science ®Google Scholar
• Blumberg N, Heal JM, Murphy P, et al. The Association between number of red cell transfusions and cancer recurrence suggests a dose-response relationship. Blood 1986; 68: 294a, Suppl 1, abstr
   Google Scholar
• Shankey TV, Eyster ME. The acquired immune deficiency syndrome (AIDS) in hemophiliacs: a hypothesis. AIDS Res 1983; 1: 83–90
   PubMedGoogle Scholar
• Hsia S, Shockley RK, Lutcher CL, et al. Unregulated production of virus and for sperm specific anti-idiotypic antibodies as a cause of AIDS. Lancet 1984; i: 1212–1214
   Google Scholar
• Shearer GM, Levy RB. Noninfectious cofactors in susceptibility to AIDS: possible contributions of semen, HLA alloantigens and lack of natural resistance. Ann NY Acad Sci 1984; 437: 49–57
   PubMed Web of Science ®Google Scholar
• Ablin RJ. Transglutaminase: co-factos in aetiology of AIDS?. Lancet 1985; 813–814
   PubMed Web of Science ®Google Scholar
• Little JR, Shore V. Modulation by lipoproteins of amphotericin B-induced immunostimulation. Cell Immunol 1985; 93: 212–221
   PubMed Web of Science ®Google Scholar
• NIH. 1980, DHHS Publication No. 81-1773
   Google Scholar
• Margolese RG, Wainberg MA. Diminished responsiveness of virus co-incubated lymphocytes to a T cell growth factor in breast cancer patients. Viral Mechanism of Immunosuppression. Alan R. Liss, New York 1985; 193–203
   Google Scholar
• Weese JL, Gilbertson EM, Syrjala SE, Starling JR. Prevention of rat colon cancer metastases by perioperative immunostimulation. Surgery 1984; 96: 420–426
   PubMed Web of Science ®Google Scholar
• O'Dwyer P, Dodson T, Ravikumar T, Steele G, Jr. The effect of alloimmunization on recurrence in an experimental colon cancer model. Cancer 1986; 57: 549–553
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administraiton of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485–1492
   PubMed Web of Science ®Google Scholar
• Herberman RB, Reynolds CW, Ortaldo JR. Mechanism of cytotoxicity by natural killer (NK) cells. Ann Rev Immunol 1986; 4: 651–680
   PubMed Web of Science ®Google Scholar
• Nordman E, Lehto I, Toivanen A. Immune functions and the prognosis of patients with solid tumours. Cancer Immunol Immunother 1985; 20: 38–42
   PubMed Web of Science ®Google Scholar
• Vanky F, Klein E, Willems J, et al. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Cancer Immunol Immunother 1986; 21: 69–76
   PubMed Web of Science ®Google Scholar
• Shenton BK, Proud G, Smith BM, Taylor RMR. Identification of immmunosuppressive factors in plasma following multiple blood transfusions. Transplant Proc 1979; 11: 171–174
   PubMed Web of Science ®Google Scholar
• Fischer E, Lenhard V, Seifert P, et al. Blood transfusion-induced suppression of cellular immunity in man. Human Immunol 1980; 3: 187–194
   Web of Science ®Google Scholar
• Kerman RH, Van Buren CT, Payne W, et al. Influence of blood transfusions on immune responsiveness. Transplant Proc 1982; 14: 335–337
   PubMed Web of Science ®Google Scholar
• Hamid J, Bancewicz J, Brown R, et al. The significance of changes in blood lymphocyte populations following surgical operations. Clin Exp Immunol 1984; 56: 49–57
   PubMed Web of Science ®Google Scholar
• Jason J, Hilgartner M, Holman RC, et al. Immune status of blood product recipients. JAMA 1985; 253: 1140–1145
   PubMed Web of Science ®Google Scholar
• Fernandez LA, MacSween JM, You CK, Gorelick M. Study of immunological changes after blood transfusion. Blood 1985; 66: 276a, Suppl 1, abstr
   Google Scholar
• Lennard TWJ, Shenton BK, Borzotta A, et al. The influence of surgical operations on components of the human immune system. Br J Surg 1985; 72: 771–776
   PubMed Web of Science ®Google Scholar
• Akbar AN, Fitzgerald-Bocarsly A, de Sousa M, et al. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload. J Immunol 1986; 136: 1635–1640
   PubMed Web of Science ®Google Scholar
• Lynch FA, Kirov SM. Changes in blood lymphocyte populations following surgery. J Clin Lab Immunol 1986; 20: 75–79
   PubMedGoogle Scholar
• Nanishi F, Inenaga T, Onoyama K, et al. Immune alterations in hemodialyzed patients. I. effect of blood transfusion on T-lymphocyte subpopulations in hemodialyzed patients. J Clin Lab Immunol 1986; 191: 167–174
   Google Scholar
• Tartter PI, Heimann TM, Aufses AH, Jr. Blood transfusion, skin test reactivity, and lymphocytes in inflammatory bowel disease. Am J Surgery 1986; 151: 358–361
   PubMed Web of Science ®Google Scholar
• Fielding LP. Red for danger: blood transfusion and colorectal cancer. Br Med J 1985; 291: 841–842
   PubMed Web of Science ®Google Scholar
• Harnblin TJ. Blood tranafusions and cancer: anomalies explained?. Br Med J 1986; 293: 517–518
   Web of Science ®Google Scholar
• Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986; 152: 479–482
   PubMed Web of Science ®Google Scholar
• Waymack JP, Rapien J, Garnea D, et al. Effect of transfusion on immune function in a traumatized animal model. Arch Surg 1986; 121: 50–55
   PubMed Web of Science ®Google Scholar
• Waymack JP, Gallon L, Barcelli U, Alexander JW. Effect of blood transfusions on macrophage function in a burned animal model. Curr Surg 1986; 43: 305–307
   PubMedGoogle Scholar
• Morfini M, Vannucchi AM, Grossi A, et al. Direct evidence that high dose intravenous gamma globulin blocks splenic and hepatic sequestration of 51Cr-labeled platelets in ITP. Thromb Haemo 1985; 54: 554
   PubMed Web of Science ®Google Scholar
• Neppert J, Clernens M, Mueller-Eckhardt C. Immune phagocytosis inhibition by commercial immunoglobulins. Blut 1986; 52: 67–72
   PubMedGoogle Scholar
• Schneidkraut MT, Loegenng DJ. Reticuloendothelial system depression with hemolyzed blood. Adv Shock Res 1980; 3: 273–282
   PubMedGoogle Scholar
• Hardy AM, Allen JR, Morgan WM, Curran JW. The incidence rate of AIDS in selected populations. JAMA 1985; 253: 215–220
   PubMed Web of Science ®Google Scholar
• Curran JW, Lawrence DN, Jaffe H, et al. AIDS Associated with transfusions. N Engl J Med 1984; 310: 69–75
   PubMed Web of Science ®Google Scholar
• Giardina PJ, Akbar AN, Salahuddin SZ, et al (1985) AIDS in a thalassemic patient transfused with frozen thawed washed red cells. International Conference on AIDS. 14-17 April, 1985. American College of Physicians as a supplement to the Annals of Internal Medicine, Atlanta, GA, 73
   Google Scholar
• Madhok R, Gracie A, Lowe GDO, et al. Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br. Med J 1986; 293: 978–980
   Web of Science ®Google Scholar
• Wachter H, Fuchs D, Hausen A, et al. Who will get AIDS?. Lancet 1986; ii: 1216–1217, Letter
   Google Scholar